Zai Lab (ZLAB) EBT Margin (2020 - 2026)

Zai Lab has disclosed EBT Margin across 7 years of filings, most recently posting 49.77% for Q1 2026.

• EBT Margin for Q1 2026 came in at 49.77%, up 573733.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 3766.82% (up 362997.0% YoY), and the FY2025 annual result was 5948.8%, up 1241570.0% from the prior year.
• EBT Margin came in at 49.77% for Q1 2026 at Zai Lab, down from 16.18% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 151.96% in Q4 2023 to a low of 20069.25% in Q2 2024.
• The 5-year median for EBT Margin is 64.01% (2023), against an average of 1909.91%.
• Across the five-year window, EBT Margin slumped 12357 bps in 2024 and surged 2003191 bps in 2025, its largest moves.
• Zai Lab's EBT Margin stood at 99.56% in 2022, then jumped by 253 bps to 151.96% in 2023, then sank by 81 bps to 28.39% in 2024, then plunged by 43 bps to 16.18% in 2025, then plunged by 408 bps to 49.77% in 2026.
• The last three EBT Margin figures came in at 49.77% (Q1 2026), 16.18% (Q4 2025), and 30.98% (Q3 2025), per Business Quant data.